Loxicom Injection For Dogs And Cats
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery in dogs. Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery in cats. Change active ingredient to: Each ml contains: Meloxicam 5 mg
Target Species: Dogs & cats
-
Active Ingredient
Each ml contains: Meloxicam 20 mg
-
Pharmaceutical Form
Solution for injection. A yellow solution.
-
Indications
Dogs:
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. Reduction
of post-operative pain and inflammation following orthopaedic and soft tissue surgery.
Cats:
Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery. -
Dosage
Dogs:
Musculo-skeletal disorders: Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg
bodyweight (i.e. 0.4 ml/10 kg bodyweight). Loxicom 1.5 mg/ml oral suspension and Loxicom
0.5 mg/ml oral suspension may be used for continuation of treatment at a dosage of 0.1 mg
meloxicam/kg bodyweight, 24 hours after administration of the injection.
Reduction of post-operative pain (over a period of 24 hours): Single intravenous or subcutaneous
injection at a dosage of 0.2 mg meloxicam/kg bodyweight (i.e. 0.4 ml/10 kg bodyweight) before
surgery, for example at the time of induction of anaesthesia.
Cats:
Reduction of post-operative pain in cats where no oral follow-up treatment is possible e.g. feral cats:
Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg bodyweight (i.e. 0.06 ml/kg
bodyweight) before surgery, for example at the time of induction of anaesthesia. In this case do not
use oral follow up treatment.
Reduction of post-operative pain in cats when administration of meloxicam is to be continued as an
oral follow-up therapy:
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e. 0.04 ml/kg body
weight) before surgery, for example at the time of induction of anaesthesia.
To continue treatment for up to five days, this initial dose may be followed 24 hours later by
administration of Loxicom 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg
body weight. The oral follow-up dose may be administered for up to a total of four doses at 24 hour
intervals.
Particular care should be taken with regard to the accuracy of dosing.
A suitably graduated 1 ml syringe should be used for administration of the product to cats.
Avoid introduction of contamination during use.
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.
Prefer to speak directly to a member of our team?
Norbrook Laboratories (Ireland) Ltd
We are open Mon - Fri 9:00am - 5:00pm